$IMLFF NEW YORK, NY / ACCESSWIRE / February 16, 2017 / Traders News Source, a leading independent equity research and corporate access firm focused on small and micro-cap public companies is covering InMed Pharmaceuticals Inc. (IMLFF). During 2016, ImMed achieved some significant milestones, including: induction of strong biopharmaceutical expertise in their senior management team, financial closures to fund continued drug/disease target identification, advanced analysis of existing datasets to ensure clinical development plans are accurate and positioned to maximize the likelihood for positive outcomes, validation and advancement of the manufacturing process, filing of provisional patents, and expanded scope of opportunities for cannabinoid-based products.
